We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:RNAC
​
​
logo

Cartesian Therapeutics (RNAC)

Nasdaq • RNAC • US8162123025

6.89Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 26, 2026, ORTEX estimated 15.4% of free float sold short, 12.1 days to cover, cost to borrow 1.14%. Sign up for live short interest data.

Market Cap

210m USD | # 7373 in US

Volume

132.16k shares | 1.03m USD

Shares Outstanding

30.5m

Free Float Shares

38.48% | 11.74m

DB:1S70

News

RNAC key data

Cartesian Therapeutics (Nasdaq: RNAC) has a market capitalization of $210.17M. Last close $6.89 (as of 2026-11-11); 52-week range $5.60 to $11.00. ORTEX data as of 2026-10-26: short interest was 15.35% of free float, 12.1 days to cover and the average cost to borrow was 1.14%. Sign up for live short interest data.

  • RNAC news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.